Search hospitals > Indiana > Michigan City
Woodland Cancer Care Center
Claim this profileMichigan City, Indiana 46360
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
94 reported clinical trials
9 medical researchers
Summary
Woodland Cancer Care Center is a medical facility located in Michigan City, Indiana. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Woodland Cancer Care Center is involved with conducting 94 clinical trials across 205 conditions. There are 9 research doctors associated with this hospital, such as Nibal Saad, Meghana Raghavendra, Taylor M. Ortiz, and Michael Eaton, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Nibal SaadMemorial Hospital of South Bend4 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
22 reported clinical trials
56 drugs studied
Meghana RaghavendraFranciscan Health Indianapolis4 years of reported clinical research
Studies Colorectal Cancer
Studies Adenocarcinoma
12 reported clinical trials
28 drugs studied
Taylor M. OrtizFranciscan Health Indianapolis1 year of reported clinical research
Studies Cancer
Studies Breast Cancer
7 reported clinical trials
19 drugs studied
Michael Eaton, MDFranciscan Health Indianapolis5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
14 drugs studied
Clinical Trials running at Woodland Cancer Care Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Colorectal Cancer
Rectal Cancer
Cancer
Colon Cancer
ALK Gene Rearrangement
Lung Adenocarcinoma
Squamous Cell Carcinoma
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Woodland Cancer Care Center?
Woodland Cancer Care Center is a medical facility located in Michigan City, Indiana. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Woodland Cancer Care Center is involved with conducting 94 clinical trials across 205 conditions. There are 9 research doctors associated with this hospital, such as Nibal Saad, Meghana Raghavendra, Taylor M. Ortiz, and Michael Eaton, MD.